Click here to get full coverage on CPRX or UTHR: Which Is the Better Value Stock Right Now? - Yahoo Finance

CPRX or UTHR: Which Is the Better Value Stock Right Now?  Yahoo Finance

CPRX or UTHR: Which Is the Better Value Stock Right Now? - Yahoo Finance

Click here to get full coverage on Is It Too Late To Consider Catalyst Pharmaceuticals (CPRX) After Strong Multi Year Rerating? - simplywall.st

Is It Too Late To Consider Catalyst Pharmaceuticals (CPRX) After Strong Multi Year Rerating?  simplywall.st

Is It Too Late To Consider Catalyst Pharmaceuticals (CPRX) After Strong Multi Year Rerating? - simplywall.st

Click here to get full coverage on Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know - Zacks Investment Research

Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know  Zacks Investment Research

Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know - Zacks Investment Research

Click here to get full coverage on JPMorgan Chase & Co. Sells 54,915 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

JPMorgan Chase & Co. Sells 54,915 Shares of Catalyst Pharmaceuticals, Inc. $CPRX  MarketBeat

JPMorgan Chase & Co. Sells 54,915 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Click here to get full coverage on AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI

AI Investing Insights - Official Homepage - Intellectia AI™  Intellectia AI

AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Still Attractively Priced After Recent Share Price Stability? - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Attractively Priced After Recent Share Price Stability?  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Attractively Priced After Recent Share Price Stability? - Yahoo Finance

Click here to get full coverage on Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Mixed Long Term And Recent Shareholder Returns - Sahm

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Mixed Long Term And Recent Shareholder Returns  Sahm

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Mixed Long Term And Recent Shareholder Returns - Sahm

Click here to get full coverage on Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Trading And DCF Upside Signals - Yahoo Finance

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Trading And DCF Upside Signals  Yahoo Finance

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Trading And DCF Upside Signals - Yahoo Finance

Click here to get full coverage on CPRX Apr 2026 17.500 call (CPRX260417C00017500) interactive stock chart - Yahoo Finance Singapore

CPRX Apr 2026 17.500 call (CPRX260417C00017500) interactive stock chart  Yahoo Finance Singapore

CPRX Apr 2026 17.500 call (CPRX260417C00017500) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on CPRX vs. UTHR: Which Stock Is the Better Value Option? - Yahoo Finance

CPRX vs. UTHR: Which Stock Is the Better Value Option?  Yahoo Finance

CPRX vs. UTHR: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on CPRX Apr 2026 35.000 call (CPRX260417C00035000) Interactive Stock Chart - Yahoo! Finance Canada

CPRX Apr 2026 35.000 call (CPRX260417C00035000) Interactive Stock Chart  Yahoo! Finance Canada

CPRX Apr 2026 35.000 call (CPRX260417C00035000) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Long Term Value After Rare Disease Interest? - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Long Term Value After Rare Disease Interest?  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Long Term Value After Rare Disease Interest? - Yahoo Finance

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause?  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? - Yahoo Finance

Click here to get full coverage on A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Softness - Yahoo Finance

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Softness  Yahoo Finance

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Softness - Yahoo Finance

Click here to get full coverage on Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound?  Yahoo Finance

Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Click here to get full coverage on Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for  Yahoo Finance

Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Click here to get full coverage on How A New US$200 Million Buyback At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story - Yahoo Finance

How A New US$200 Million Buyback At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story  Yahoo Finance

How A New US$200 Million Buyback At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results - Yahoo Finance

Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results  Yahoo Finance

Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results - Yahoo Finance

Click here to get full coverage on Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo Finance

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?  Yahoo Finance

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo Finance

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback? - simplywall.st

Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback?  simplywall.st

Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback? - simplywall.st

Click here to get full coverage on CPRX vs UTHR: Which Stock Offers Greater Value at This Moment? - Bitget

CPRX vs UTHR: Which Stock Offers Greater Value at This Moment?  Bitget

CPRX vs UTHR: Which Stock Offers Greater Value at This Moment? - Bitget

Click here to get full coverage on CPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

CPRX Earning Date, Earning Analysis and Earning Prediction  Intellectia AI

CPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Click here to get full coverage on What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? - Yahoo Finance

What do Analysts Think About Catalyst Pharmaceuticals (CPRX)?  Yahoo Finance

What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? - Yahoo Finance

Click here to get full coverage on Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) - Yahoo Finance

Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX)  Yahoo Finance

Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) - Yahoo Finance

Click here to get full coverage on Catalyst (CPRX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Catalyst (CPRX) Reports Q4 Earnings: What Key Metrics Have to Say  Yahoo Finance

Catalyst (CPRX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals, Inc. (CPRX) Stock Forecasts - Yahoo Finance

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Forecasts  Yahoo Finance

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Forecasts - Yahoo Finance

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now? - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now?  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now? - Yahoo Finance

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Its Strong DCF Upside After Recent Flat Returns - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Its Strong DCF Upside After Recent Flat Returns  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Its Strong DCF Upside After Recent Flat Returns - Yahoo Finance

Click here to get full coverage on CPRX Apr 2026 30.000 call (CPRX260417C00030000) interactive stock chart - Yahoo Finance Singapore

CPRX Apr 2026 30.000 call (CPRX260417C00030000) interactive stock chart  Yahoo Finance Singapore

CPRX Apr 2026 30.000 call (CPRX260417C00030000) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum - Yahoo Finance

A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum  Yahoo Finance

A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals (NASDAQ:CPRX) shareholders have earned a 41% CAGR over the last five years - Yahoo Finance

Catalyst Pharmaceuticals (NASDAQ:CPRX) shareholders have earned a 41% CAGR over the last five years  Yahoo Finance

Catalyst Pharmaceuticals (NASDAQ:CPRX) shareholders have earned a 41% CAGR over the last five years - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth  Yahoo Finance

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

Click here to get full coverage on Why Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Raising Its 2026 Revenue Outlook And What’s Next - simplywall.st

Why Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Raising Its 2026 Revenue Outlook And What’s Next  simplywall.st

Why Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Raising Its 2026 Revenue Outlook And What’s Next - simplywall.st

Click here to get full coverage on Vanguard realigns reporting; Catalyst Pharmaceuticals (CPRX) shows 0% ownership - Stock Titan

Vanguard realigns reporting; Catalyst Pharmaceuticals (CPRX) shows 0% ownership  Stock Titan

Vanguard realigns reporting; Catalyst Pharmaceuticals (CPRX) shows 0% ownership - Stock Titan

Click here to get full coverage on Is Catalyst Pharmaceuticals’ (CPRX) Upgraded Revenue Forecast Signaling a Shift in Growth Prospects? - Yahoo Finance

Is Catalyst Pharmaceuticals’ (CPRX) Upgraded Revenue Forecast Signaling a Shift in Growth Prospects?  Yahoo Finance

Is Catalyst Pharmaceuticals’ (CPRX) Upgraded Revenue Forecast Signaling a Shift in Growth Prospects? - Yahoo Finance

Click here to get full coverage on Wall Street experts foresee a potential 45.3% increase for Catalyst (CPRX): Key Information You Need to Know - Bitget

Wall Street experts foresee a potential 45.3% increase for Catalyst (CPRX): Key Information You Need to Know  Bitget

Wall Street experts foresee a potential 45.3% increase for Catalyst (CPRX): Key Information You Need to Know - Bitget

Click here to get full coverage on Patent trial on Catalyst (NASDAQ: CPRX) FIRDAPSE® patents delayed to May 18, 2026 - Stock Titan

Patent trial on Catalyst (NASDAQ: CPRX) FIRDAPSE® patents delayed to May 18, 2026  Stock Titan

Patent trial on Catalyst (NASDAQ: CPRX) FIRDAPSE® patents delayed to May 18, 2026 - Stock Titan

Click here to get full coverage on Catalyst Pharmaceuticals (CPRX) Net Margin Strength Reinforces Bullish Earnings Narrative - simplywall.st

Catalyst Pharmaceuticals (CPRX) Net Margin Strength Reinforces Bullish Earnings Narrative  simplywall.st

Catalyst Pharmaceuticals (CPRX) Net Margin Strength Reinforces Bullish Earnings Narrative - simplywall.st

Click here to get full coverage on Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock  Yahoo Finance

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceutical (CPRX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance

Catalyst Pharmaceutical (CPRX) Recently Broke Out Above the 20-Day Moving Average  Yahoo Finance

Catalyst Pharmaceutical (CPRX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance

Click here to get full coverage on Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum Cooldown - Sahm

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum Cooldown  Sahm

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum Cooldown - Sahm

Click here to get full coverage on Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi‑Year Share Price Surge? - Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi‑Year Share Price Surge?  Yahoo Finance

Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi‑Year Share Price Surge? - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals (CPRX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Catalyst Pharmaceuticals (CPRX) Stock Falls on Q4 2025 Earnings  Quiver Quantitative

Catalyst Pharmaceuticals (CPRX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Presents a Compelling Value Investment Case - chartmill.com

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Presents a Compelling Value Investment Case  chartmill.com

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Presents a Compelling Value Investment Case - chartmill.com

Click here to get full coverage on Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For  Yahoo Finance

Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals (NASDAQ: CPRX) FIRDAPSE patent trial pushed to May 2026 - Stock Titan

Catalyst Pharmaceuticals (NASDAQ: CPRX) FIRDAPSE patent trial pushed to May 2026  Stock Titan

Catalyst Pharmaceuticals (NASDAQ: CPRX) FIRDAPSE patent trial pushed to May 2026 - Stock Titan

Click here to get full coverage on Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates  Yahoo Finance

Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Ahead of Catalyst (CPRX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance

Ahead of Catalyst (CPRX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics  Yahoo Finance

Ahead of Catalyst (CPRX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance

Click here to get full coverage on Real-world Duchenne data: how a novel steroid is used in care - Stock Titan

Real-world Duchenne data: how a novel steroid is used in care  Stock Titan

Real-world Duchenne data: how a novel steroid is used in care - Stock Titan

Click here to get full coverage on Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term  Yahoo Finance

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Truist Financial Upgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to "Strong-Buy" - MarketBeat

Truist Financial Upgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to "Strong-Buy"  MarketBeat

Truist Financial Upgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to "Strong-Buy" - MarketBeat

Click here to get full coverage on Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on CPRX vs. ZTS: Which Stock Is the Better Value Option? - Yahoo Finance

CPRX vs. ZTS: Which Stock Is the Better Value Option?  Yahoo Finance

CPRX vs. ZTS: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Screens as an Affordable Growth Stock - chartmill.com

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Screens as an Affordable Growth Stock  chartmill.com

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Screens as an Affordable Growth Stock - chartmill.com

Click here to get full coverage on Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on 5 Small Drug Stocks to Buy as Sector Recovery Gains Strength - The Globe and Mail

5 Small Drug Stocks to Buy as Sector Recovery Gains Strength  The Globe and Mail

5 Small Drug Stocks to Buy as Sector Recovery Gains Strength - The Globe and Mail

Click here to get full coverage on (CPRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

(CPRX) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

(CPRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Click here to get full coverage on Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Yahoo Finance

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock  Yahoo Finance

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Yahoo Finance

Click here to get full coverage on Zacks Research Analysts Boost Earnings Estimates for CPRX - MarketBeat

Zacks Research Analysts Boost Earnings Estimates for CPRX  MarketBeat

Zacks Research Analysts Boost Earnings Estimates for CPRX - MarketBeat

Click here to get full coverage on CPRX vs. DSNKY: Which Stock Is the Better Value Option? - Yahoo Finance

CPRX vs. DSNKY: Which Stock Is the Better Value Option?  Yahoo Finance

CPRX vs. DSNKY: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - simplywall.st

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?  simplywall.st

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - simplywall.st

Click here to get full coverage on Does Catalyst Pharmaceuticals (NASDAQ:CPRX) Deserve A Spot On Your Watchlist? - simplywall.st

Does Catalyst Pharmaceuticals (NASDAQ:CPRX) Deserve A Spot On Your Watchlist?  simplywall.st

Does Catalyst Pharmaceuticals (NASDAQ:CPRX) Deserve A Spot On Your Watchlist? - simplywall.st

Click here to get full coverage on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Strong Buy" by Brokerages - MarketBeat

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Strong Buy" by Brokerages  MarketBeat

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Strong Buy" by Brokerages - MarketBeat

Click here to get full coverage on Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Fundamentals with a Technical Breakout Setup - chartmill.com

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Fundamentals with a Technical Breakout Setup  chartmill.com

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Fundamentals with a Technical Breakout Setup - chartmill.com

Click here to get full coverage on Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) (CPRX) - Seeking Alpha

Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) (CPRX)  Seeking Alpha

Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) (CPRX) - Seeking Alpha

Click here to get full coverage on Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035 - Yahoo Finance

Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035  Yahoo Finance

CPRX

Price Chart

Key Statistics

Technicals

About CPRX

Latest News

CPRX or UTHR: Which Is the Better Value Stock Right Now? - Yahoo Finance

Is It Too Late To Consider Catalyst Pharmaceuticals (CPRX) After Strong Multi Year Rerating? - simplywall.st

Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should Know - Zacks Investment Research

Advanced Charts

Top Gainers

Top Losers